← Glossary

Investigational New Drug Application

IND

FDA & Regulatory

An Investigational New Drug (IND) application is the request a sponsor files with the FDA to begin human clinical trials. Clearance of the IND allows a candidate to move from preclinical work into Phase 1.

Related terms

Phase 1 TrialNew Drug Application

Track Investigational New Drug Application across 1,000+ biotechs

BioSniper monitors FDA decisions, clinical trials, and catalysts in real time — with evidence-backed AI analysis.

Start Free